Page last updated: 2024-10-21

acebutolol and Acquired Laryngeal Stenosis

acebutolol has been researched along with Acquired Laryngeal Stenosis in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Research Excerpts

ExcerptRelevanceReference
"The successful management of subglottic hemangioma with propranolol has been reported."7.76Management of infantile subglottic hemangioma: acebutolol or propranolol? ( Amedro, P; Bigorre, M; Blanchet, C; Mondain, M; Nicollas, R, 2010)
"The successful management of subglottic hemangioma with propranolol has been reported."3.76Management of infantile subglottic hemangioma: acebutolol or propranolol? ( Amedro, P; Bigorre, M; Blanchet, C; Mondain, M; Nicollas, R, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanchet, C1
Nicollas, R1
Bigorre, M1
Amedro, P1
Mondain, M1

Other Studies

1 other study available for acebutolol and Acquired Laryngeal Stenosis

ArticleYear
Management of infantile subglottic hemangioma: acebutolol or propranolol?
    International journal of pediatric otorhinolaryngology, 2010, Volume: 74, Issue:8

    Topics: Acebutolol; Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Drug Administration Sched

2010